Icodextrin vs. Glucose 2.5% on survival of patients on Peritoneal Dialysis

Not Applicable

Recruiting

• Conditions: hypertension; N180; Diabetes Mellittus

• Registration Number: RBR-97z4wh6
• Lead Sponsor: daniela ponce

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-08-30
• Study Completion: 2022-03-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Adult patients that initiated unplanned PD on treatment with APD for at least 90 days and with a recent peritoneal equilibration test (PET) showing a Dialysate/Plasma creatinine of higher than 0.50; low-average; highaverage or high transporter have been included in the study.

Exclusion Criteria

Exclusion criteria include life expectancy of lower than1 year at baseline, positive sorology for human imunodeficiency virus (HIV); a peritonitis episode preceding the randomization by 1 month; any hospitalization due to cardiovascular, metabolic or infectious disease in the month preceding randomization; any known active cancer; pregnancy; and known allergy to icodextrin 7.5%

Study & Design

• Study Type: Intervention
• Study Design: Not specified